Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerie G Montana

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemistry|August 6, 2003
Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinityThomas B Stanley, Lisa M Leesnitzer, Valerie G Montana, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activityMarcos L Sznaidman, Curt D Haffner, Patrick R Maloney, et al.
Journal of Medicinal Chemistry|April 2, 2004
Structure-based design of potent retinoid X receptor alpha agonistsCurt D Haffner, James M Lenhard, Aaron B Miller, et al.
Cell|August 2, 2002
Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognitionRandy K Bledsoe, Valerie G Montana, Thomas B Stanley, et al.
Nature|February 15, 2002
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalphaH Eric Xu, Thomas B Stanley, Valerie G Montana, et al.
Journal of Medicinal Chemistry|January 25, 2007
Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agentsMichael L Sierra, Véronique Beneton, Anne-Bénédict Boullay, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemistry|August 6, 2003
Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinityThomas B Stanley, Lisa M Leesnitzer, Valerie G Montana, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activityMarcos L Sznaidman, Curt D Haffner, Patrick R Maloney, et al.
Journal of Medicinal Chemistry|April 2, 2004
Structure-based design of potent retinoid X receptor alpha agonistsCurt D Haffner, James M Lenhard, Aaron B Miller, et al.
Cell|August 2, 2002
Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognitionRandy K Bledsoe, Valerie G Montana, Thomas B Stanley, et al.
Nature|February 15, 2002
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalphaH Eric Xu, Thomas B Stanley, Valerie G Montana, et al.
Journal of Medicinal Chemistry|January 25, 2007
Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agentsMichael L Sierra, Véronique Beneton, Anne-Bénédict Boullay, et al.
Pageof 1